ID   LB905-BLC
AC   CVCL_E905
SY   LB905
DR   Wikidata; Q54902103
RX   PubMed=9637538;
RX   PubMed=11051255;
RX   PubMed=11751535;
RX   PubMed=29732388;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
RX   PubMed=9637538; DOI=10.4049/jimmunol.160.12.6188;
RA   Gueguen M., Patard J.-J., Gaugler B., Brasseur F., Renauld J.-C.,
RA   Van Cangh P.J., Boon T., van den Eynde B.J.;
RT   "An antigen recognized by autologous CTLs on a human bladder
RT   carcinoma.";
RL   J. Immunol. 160:6188-6194(1998).
//
RX   PubMed=11051255;
RA   Gala J.-L., Loric S., Guiot Y., Denmeade S.R., Gady A., Brasseur F.,
RA   Heusterspreute M., Eschwege P., De Nayer P., Van Cangh P.J., Tombal B.;
RT   "Expression of prostate-specific membrane antigen in transitional cell
RT   carcinoma of the bladder: prognostic value?";
RL   Clin. Cancer Res. 6:4049-4054(2000).
//
RX   PubMed=11751535; DOI=10.1093/clinchem/48.1.25;
RA   Zammatteo N., Lockman L., Brasseur F., De Plaen E., Lurquin C.,
RA   Lobert P.-E., Hamels S., Boon T., Remacle J.;
RT   "DNA microarray to monitor the expression of MAGE-A genes.";
RL   Clin. Chem. 48:25-34(2002).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//